Pacira BioSciences' Gains from Investment Securities rose 9930.37% to $16.9 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 13032.61%. This contributed to the annual value of -$4.5 million for FY2024, which is 3016.94% down from last year.
As of Q2 2025, Pacira BioSciences' Gains from Investment Securities stood at $16.9 million, which was up 9930.37% from -$5.9 million recorded in Q1 2025.
In the past 5 years, Pacira BioSciences' Gains from Investment Securities ranged from a high of $16.9 million in Q2 2025 and a low of -$21.3 million during Q2 2022
Over the past 5 years, Pacira BioSciences' median Gains from Investment Securities value was -$319500.0 (recorded in 2021), while the average stood at -$1.3 million.
Its Gains from Investment Securities has fluctuated over the past 5 years, first skyrocketed by 118478.06% in 2023, then tumbled by 341725.77% in 2024.
Over the past 5 years, Pacira BioSciences' Gains from Investment Securities (Quarter) stood at $404000.0 in 2021, then plummeted by 1605.45% to -$6.1 million in 2022, then skyrocketed by 106.95% to $423000.0 in 2023, then crashed by 3417.26% to -$14.0 million in 2024, then skyrocketed by 220.35% to $16.9 million in 2025.
Its last three reported values are $16.9 million in Q2 2025, -$5.9 million for Q1 2025, and -$14.0 million during Q4 2024.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value